Get startedLog in
    Picture of InBioGen Co logo

    101140 — InBioGen Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    IndustrialsHighly SpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for InBioGen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-45,07894,125-119,68718,85716,122
    Depreciation
    Amortisation
    Non-Cash Items41,006-101,259107,843-23,597-20,022
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-4,405-1,052-1,0992,4652,809
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-8,033-7,069-11,505-1,051-33.1
    Capital Expenditures-971-2,402-331-331-84.3
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-4,895-38,035-15,59413810.1
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-5,866-40,437-15,925-193-74.2
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities14,97061,54313,568-1,957-265
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash1,07214,038-13,862-3,201-373